Immunomic Therapeutics Announces Promotion of Teri Heiland, Ph.D. to Chief Scientific Officer

Published on :

Immunomic Therapeutics Announces Promotion of Teri Heiland, Ph.D. to Chief Scientific Officer June 20, 2019 04:05 PM Eastern Daylight Time ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based [….]